Skip to main content
. 2014 Jun 23;3(3):e000961. doi: 10.1161/JAHA.114.000961

Figure 1.

Figure 1.

AID‐TAT peptide decreases ischemia‐reperfusion (I/R) injury in hearts ex vivo. A, Representative sections from guinea pig hearts after I/R treated with 1 μmol/L of scrambled (AID(S)‐TAT) or active (AID‐TAT) peptides. Infarct size is assessed as area that did not take up nitroblue tetrazolium dye. B, Mean±SEM of infarct size expressed as percentage (%) of total left ventricular (LV) area for all hearts treated with AID(S)‐TAT or AID‐TAT as indicated. C, Creatine kinase (CK) activity of hearts treated with 1 μmol/L of scrambled (AID(S)‐TAT) or active (AID‐TAT) peptides before (Pre) and after (Post) ischemia as indicated. D, Lactate dehydrogenase (LDH) activity of hearts treated with 1 μmol/L of scrambled (AID(S)‐TAT) or active (AID‐TAT) peptides before (Pre) and after (Post) ischemia as indicated. E, GSH/GSSG ratio of hearts treated with 1 or 10 μmol/L of scrambled (AID(S)‐TAT) or active (AID‐TAT) peptides before (Pre) and after (Post) ischemia as indicated. n represents number of hearts. Statistical significance was determined using the Kruskal‐Wallis test followed by Dunn's multiple comparison test. AID indicates alpha‐interacting domain; GSH/GSSG, glutathione to oxidized glutathione; TAT, transactivator of transcription.